Patient recruitment and retention remain persistent challenges in oncology clinical trials, often leading to delays, increased costs and compromised data validity. Traditional recruitment strategies f

Objective: To evaluate the clinical efficacy and translational relevance of Claudin-18.2 (CLDN18.2)–targeted therapy in advanced gastric and gastro-oesophageal junction adenocarcinoma, and to assess i